United First Partners Serves as Introducing Broker on Mayflower IPO, a UK Listed Acquisition Vehicle and Among the Largest Primary New Issues in London in 2025, Highlighting UFP’s Increasing Presence Across ECM
10.12.2025 18:42:00 CET | Business Wire | Press Release
United First Partners (“UFP”) is pleased to announce its role as Introducing Broker on Mayflower Acquisition Limited (“Mayflower”), which completed its IPO today, raising USD 500 million. The size of the capital raised places Mayflower among the largest London acquisition vehicles of recent years.
The offering represents an important development for UFP’s expanding capital markets platform and reflects the firm’s increasing activity within Equity Capital Markets (ECM).
About Mayflower Acquisition Limited
Mayflower is a UK Listed Acquisition Vehicle, sponsored by TOMS Capital and JRJ Group, incorporated to unlock exits across a closely-held company universe, including long-held private equity assets and large family-owned businesses.
Mayflower’s structure provides guaranteed capital to asset owners, offering a flexible liquidity solution and higher potential for transaction success, and highly aligned economics to investors, with a significant Sponsor commitment of USD 75m.
Mayflower was founded by Noam Gottesman, Sir Jeremy Isaacs CBE, and Roger Nagioff, who have a working relationship of over three decades and a strong track record of sourcing acquisition opportunities and building businesses both through organic growth and executing accretive M&A strategies that deliver shareholder value.
UFP’s Expanding Focus in ECM
UFP’s participation in the Mayflower IPO aligns with the firm’s broader strategy to continue developing its ECM offering.
Building on its established strengths in event-driven and special situations research and distribution, UFP is investing in capabilities across:
- IPO and SPAC origination and distribution
- Block trades and equity placements
- Equity-linked transactions
- Cross-border capital markets solutions
“Our work on the Mayflower transaction illustrates the direction of our growing ECM platform,” said Michael Hadjedj, Founder and CEO of UFP.
“We aim to participate in transactions where our global reach and cross-market expertise can provide constructive support to clients.”
About United First Partners
United First Partners (“UFP”) is a global financial services organization specializing in event-driven advisory, special situations, and equity-derivatives execution.
With offices across major financial hubs, UFP provides market intelligence, conflict-free advice, and institutional-grade execution to corporates, hedge funds, and asset managers worldwide.
UFP operates through regulated entities including, in the US, United First Partners LLC is a registered broker/dealer and member of FINRA and SIPC.
In the UK & Australia, “UFP London” and “United First Partners” are registered trading names of Mariana UFP LLP (FRN 551170) and Mariana UFP SAS (FRN 989397) which are authorized and regulated by the Financial Conduct Authority.
In France, “United First Partners” is a registered trading name of Mariana UFP SAS, authorized and regulated by the ACPR & AMF (BIC Code 14483).
In the UAE, Mariana UFP Capital Markets (DIFC) Limited is regulated by the DFSA (RN F002918) and is licensed to conduct broking activities.
Registered as Limited Liability Company in the State of New York. USA
United First Partners, LLC is a registered Broker/Dealer and a member of FINRA and SIPC
View source version on businesswire.com: https://www.businesswire.com/news/home/20251210254196/en/
Contacts
For media inquiries:
Harpreet Ghumaan
1-212-266-5644
harpreet.ghumaan@utdfirst.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission for Palmoplantar Pustulosis3.3.2026 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodiesterase-4 (PDE4) inhibitor, has been granted orphan medicinal product designation by the European Commission (EC) for the treatment of palmoplantar pustulosis (PPP). Palmoplantar pustulosis is a chronic inflammatory disease characterized by the development of multiple sterile pustules on the palms and soles. Patients often experience pain and pruritus of the skin, and the condition can be accompanied by nail involvement and joint pain. Because lesions on the palms are visible to others and lesions on the soles can cause pain while walking, daily functioning can be significantly restricted, leading in a substantial reduction in quality of life. PPP has a pathophysiology distinct from psoriasis and pustular psoriasis, and treatment can be challenging, unde
Yubico Establishes Singapore as Third Global Headquarters Accelerating Asia Pacific Growth3.3.2026 01:00:00 CET | Press Release
Yubico (NASDAQ STOCKHOLM: YUBICO), a cybersecurity company, inventor of FIDO passkeys and creator of the YubiKey, the most secure passkey, today announced the opening of its third global headquarters in Singapore. This announcement reinforces Yubico’s long-term commitment to the Asia Pacific region and builds on its role in advancing open authentication standards, while shaping a safer digital world for all. The new office complements Yubico’s existing global headquarters in Stockholm, Sweden and Santa Clara, USA, reflecting its strategy to serve a growing international user base by helping customers deploy YubiKeys at scale to adapt to a rapidly evolving cybersecurity landscape. “As the digital economy grows, there’s a decisive shift across Asia Pacific, where organizations are moving beyond legacy multi-factor authentication to meet rigorous new national regulations for identity protection,” said Jerrod Chong, Acting Chief Executive Officer at Yubico, a Singaporean. “The expansion of
IFF Completed the Divestiture of Soy Crush, Concentrates and Lecithin Businesses2.3.2026 22:15:00 CET | Press Release
IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its soy crush, concentrates and lecithin businesses to Bunge. This transaction does not include IFF’s soy isolates business. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2026 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved. View source version on businesswire.com: https://www.businesswire.com/news/home/20260302231096/en/
Verimatrix ReAccess Earns Gold 2026 Merit Award for Telecom & Wireless2.3.2026 17:50:00 CET | Press Release
Regulatory News: Verimatrix (Euronext Paris: VMX), a leading provider of security solutions for a safer connected world, today announced that its Verimatrix ReAccess solution was honored with a gold 2026 Merit Award for Telecom & Wireless. The industry accolade recognizes the company’s next-generation content security solution that modernizes legacy Conditional Access Systems (CAS) across DVB, IPTV and OTT networks without requiring costly hardware replacements or field service interventions. Judged by industry executives, media professionals and technology consultants, the Merit Awards evaluate submissions from across the telecommunications landscape. Verimatrix ReAccess enables secure, over-the-air (OTA) software updates to deployed set-top boxes (STBs), delivering operator cost savings, reduced operational complexity, and ongoing protection against piracy. It also empowers operators to continuously strengthen content security, eliminating the need for costly hardware replacements. U
Textron Aviation Launches Donation Campaign to Support 2026 Special Olympics Airlift; Continues Nationwide Call for Volunteer Doves2.3.2026 17:00:00 CET | Press Release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced the launch of a donation campaign benefitting Special Olympics in support of the 2026 Special Olympics Airlift, a nationwide effort that brings athletes and coaches to the Special Olympics USA Games through the generosity of volunteer pilots, aircraft owners and operators known as Doves. Financial contributions go directly to the Special Olympics, a 501(c)(3) charitable organization. New for the 2026 event, the donation campaign serves a vital role in ensuring each delegation has what it needs for a smooth and welcoming travel experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302196418/en/ Textron Aviation launches donation campaign to support 2026 Special Olympics Airlift; continues nationwide call for volunteer Doves (Photo credit: Textron Aviation). “This campaign reflects the spirit of unity and generosity that defines the Special Olym
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom